These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 805534)

  • 21. Kinetics of endotoxin release by gram-negative bacteria in the intestinal tract of mice during oral administration of bacitracin and during in vitro growth.
    Goris H; de Boer F; van der Waaij D
    Scand J Infect Dis; 1988; 20(2):213-9. PubMed ID: 2969614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Post-antibiotic effect in the treatment of infections in neutropenic patients].
    Bermudez LE
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(2):76-9. PubMed ID: 3105033
    [No Abstract]   [Full Text] [Related]  

  • 23. [Further investigations into the effectiveness of gentamicin and other antibiotics against urinary tract infection organisms (author's transl)].
    Schmid W
    Med Klin; 1976 Dec; 71(50):2214-7. PubMed ID: 826773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the endotoxin retention capabilities of inline intravenous filters.
    Horibe K; Mashima Y; Tashiro T; Yamamori H; Okui K
    JPEN J Parenter Enteral Nutr; 1990; 14(1):56-9. PubMed ID: 2109116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Time factors in the bactericidal activity of gentamycin against E. coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas pyoceanea and Staphylococcus aureus].
    Helm E; Shah PM; Stille W
    Med Welt; 1974 Apr; 25(15):644-8. PubMed ID: 4596609
    [No Abstract]   [Full Text] [Related]  

  • 27. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake of (methyl-14C)-sisomicin and (methyl-14C)-gentamicin into bacterial cells.
    Lee BK; Condon RG; Munayyer H; Weinstein MJ
    J Antibiot (Tokyo); 1978 Feb; 31(2):141-6. PubMed ID: 416011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Filtration removal of endotoxin (pyrogens) in solution in different states of aggregation.
    Sweadner KJ; Forte M; Nelsen LL
    Appl Environ Microbiol; 1977 Oct; 34(4):382-5. PubMed ID: 335971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral administration of antibiotics and intestinal flora associated endotoxin in mice.
    Goris H; de Boer F; van der Waaij D
    Scand J Infect Dis; 1986; 18(1):55-63. PubMed ID: 3008311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Survival of bacteria, and release of the endotoxin from the bacterial cells in the dialysates].
    Koga N; Sato T; Sasaki H; Ikematsu H; Kurashige Y; Harano Y; Sendou S; Hirano K; Nakamura M
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):181-9. PubMed ID: 1588769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential hazards associated with microbial contamination of in-line filters during intravenous therapy.
    Holmes CJ; Kundsin RB; Ausman RK; Walter CW
    J Clin Microbiol; 1980 Dec; 12(6):725-31. PubMed ID: 6796597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synthesis of 1-N-[(S)-4-amino-2-hydroxybutyryl]gentamicin C1 and 1-N-[ (S) -3-amino-2-hydroxypropionyl]gentamicin C1.
    Daniels PJ; Weinstein J; Nagabhushan TL
    J Antibiot (Tokyo); 1974 Nov; 27(11):889-93. PubMed ID: 4217792
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid detection of gram-negative bacteriuria by use of the Limulus endotoxin assay.
    Jorgensen JH; Carvajal HF; Chipps BE; Smith RF
    Appl Microbiol; 1973 Jul; 26(1):38-42. PubMed ID: 4580196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of endotoxin retentive intravenous filters with paediatric total parenteral nutrition solutions.
    Richards C; Thomas P
    J Clin Pharm Ther; 1990 Feb; 15(1):53-8. PubMed ID: 2108176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotoxin removal by end-line filters.
    Vanhaecke E; De Muynck C; Remon JP; Colardyn F
    J Clin Microbiol; 1989 Dec; 27(12):2710-2. PubMed ID: 2512324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in the propensity to release endotoxin after cefuroxime exposure in different gram-negative bacteria: uniform and dose-dependent reduction by the addition of tobramycin.
    Goscinski G; Lundholm M; Odenholt I; Sjölin J
    Scand J Infect Dis; 2003; 35(1):40-6. PubMed ID: 12685883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of triethylenetetramine dihydrochloride on the in vivo susceptibility of Pseudomonas aeruginosa to gentamicin.
    Light B; Riggs HG
    J Antibiot (Tokyo); 1979 Aug; 32(8):834-8. PubMed ID: 115822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbial filtrates activate granulocytes without complement or prostaglandins.
    Yellin SA; Garrity FL; Williams JJ; Slotman GJ
    Circ Shock; 1986; 19(3):275-82. PubMed ID: 3524892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane filter (pore size, 0.22-0.45 micro m; thickness, 150 micro m) passing-through activity of Pseudomonas aeruginosa and other bacterial species with indigenous infiltration ability.
    Hasegawa H; Naganuma K; Nakagawa Y; Matsuyama T
    FEMS Microbiol Lett; 2003 Jun; 223(1):41-6. PubMed ID: 12798998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.